Showing results (2351-2360 of 2,500) with videos related to
Sort By:
Pageof 250
BMC Medical Research Methodology|August 4, 2022
Selecting implementation models, theories, and frameworks in which to integrate intersectional approachesJustin Presseau, Danielle Kasperavicius, Isabel Braganca Rodrigues, et al.Journal of the American Geriatrics Society|November 14, 2017
Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network MetaanalysisAndrea C Tricco, Huda M Ashoor, Charlene Soobiah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphomaCraig H Moskowitz, Heiko Schöder, Julie Teruya-Feldstein, et al.BMC Medical Informatics and Decision Making|August 25, 2016
A randomized controlled trial comparing in-person and wiki-inspired nominal group techniques for engaging stakeholders in chronic kidney disease research prioritizationMeghan J Elliott, Sharon E Straus, Neesh Pannu, et al.American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.BMC Medicine|June 19, 2015
Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysisAndrea C Tricco, Charlene Soobiah, Erik Blondal, et al.Blood|May 9, 2001
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expressionU Lopatin, X Yao, R K Williams, et al.Blood|February 2, 2018
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCLCraig S Sauter, Matthew J Matasar, Heiko Schoder, et al.Systematic Reviews|August 14, 2014
Seeing the forests and the trees--innovative approaches to exploring heterogeneity in systematic reviews of complex interventions to enhance health system decision-making: a protocolNoah Ivers, Andrea C Tricco, Thomas A Trikalinos, et al.Blood|February 7, 2001
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelC H Moskowitz, S D Nimer, A D Zelenetz, et al.Pageof 250